Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07405294 · ClinicalTrials.gov registry record

TeleMAb Retrospective Cohort Study

A clinical trial of Telemedicine and Medication Abortion, sponsored by Columbia University.

Active
Registry status
400
Enrollment target
1
Study location

NCT07405294 is a study of Telemedicine and Medication Abortion that is active but no longer recruiting, run by Columbia University. The registered enrollment target is 400 participants, below the 4,035-participant average among 18 other Telemedicine trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07405294, a study of Telemedicine and Medication Abortion, is active but no longer recruiting, sponsored by Columbia University.

ACTIVE NOT RECRUITING
Registry status
400 participants
Enrollment target
1
Study location

Study Summary

The objective of this study is to evaluate whether there are different clinical outcomes and unscheduled follow-ups between in-person and telemedicine medication abortion, and to better understand patients' experiences with telemedicine medication abortion and their motivations for seeking unscheduled follow-up care in a setting where abortion care, including both virtual and in-person follow-up care, is readily accessible.

Interventions

  • OTHER Telemedicine Medication Abortion

Study Locations (1)

New York

  • Columbia University Irving Medical Center - New York

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 2023-06-12
Est. Completion 2026-07-31

Sponsor

Columbia University

958 total trials

What the Registry Record Tells You About NCT07405294

The ClinicalTrials.gov registry entry for NCT07405294 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,035-participant average among 18 other Telemedicine trials with a reported enrollment target (90% lower). The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Telemedicine appearing as the primary indexed condition, and to 1 intervention - of which Telemedicine Medication Abortion is the first listed.

NCT07405294 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT07405294 about?

NCT07405294 is a clinical study titled "TeleMAb Retrospective Cohort Study". The objective of this study is to evaluate whether there are different clinical outcomes and unscheduled follow-ups between in-person and telemedicine medication abortion, and to better understand patients' experiences with telemedicine medication abortion and their motivations for seeking unschedul...

What is the current status of trial NCT07405294?

This trial is currently active not recruiting. The enrollment target is 400 participants. The study started on 2023-06-12. Estimated completion is 2026-07-31.

What conditions does trial NCT07405294 study?

This clinical trial studies the following conditions: Telemedicine, Medication Abortion.

What interventions are being tested in trial NCT07405294?

The interventions under investigation include: Telemedicine Medication Abortion (OTHER).

Who is sponsoring clinical trial NCT07405294?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07405294 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Telemedicine

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.